Through comparative proteome and immunohistochemistry, we found some molecules showed higher expression in IBS than the normal controls. Those molecules are very new for intestine or IBS, at first, we wish to understand their roles in IBS or functional gastrointestinal disorders based on the clinical data, then, to explore their basic mechanisms and the therapeutic potential with experiments.
If anyone have interest in this research please join us, especially, welcome the clinical researchers who can provide the samples and data of IBS patients.